BGC
IBB icon

Beutel, Goodman & Co’s iShares Biotechnology ETF IBB Stock Holding History

Beutel, Goodman & Co’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-45
Closed -$7K – 173
2025
Q4 		$7K Hold
45
– – ﹤0.01% 158
2025
Q3 		$6K Hold
45
– – ﹤0.01% 162
2025
Q2 		$5K Hold
45
– – ﹤0.01% 165
2025
Q1 		$5K Buy
+45
New +$6.1K ﹤0.01% 190

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Beutel, Goodman & Co's IBB Position: Q1 2026 in Review

Beutel, Goodman & Co sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 45 shares — an estimated $7K sold.

Beutel, Goodman & Co first reported a position in IBB in Q1 2025 and held it in 4 quarters. The position peaked at $7K in Q4 2025. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Beutel, Goodman & Co reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
  • Beutel, Goodman & Co sold 45 iShares Biotechnology ETF shares in Q1 2026, an estimated $7K.
  • Beutel, Goodman & Co first reported a position in iShares Biotechnology ETF in Q1 2025 and held it in 4 quarters.
  • Beutel, Goodman & Co's iShares Biotechnology ETF position peaked at $7K in Q4 2025.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Beutel, Goodman & Co's 13F filing for Q1 2026, filed 15 May 2026.